Medicover Financials

5M0B Stock  EUR 15.14  0.16  1.05%   
You can employ fundamental analysis to find out if Medicover AB is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate thirty-two available fundamentals for Medicover, which can be compared to its peers in the industry. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Medicover to be traded at €14.69 in 90 days.
  
Understanding current and past Medicover Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Medicover's financial statements are interrelated, with each one affecting the others. For example, an increase in Medicover's assets may result in an increase in income on the income statement.

Medicover Stock Summary

Medicover competes with Humana, Ramsay Gnrale, Superior Plus, and Origin Agritech. Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, India, and Hungary. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. MEDICOVER operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 20970 people.
InstrumentGermany Stock View All
ExchangeFrankfurt Exchange
ISINSE0009778848
Business AddressPO Box 5283,
SectorHealthcare
IndustryHealth Care Plans
BenchmarkDow Jones Industrial
Websitewww.medicover.com
Phone46 8 40 01 76 00
CurrencyEUR - Euro
You should never invest in Medicover without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Medicover Stock, because this is throwing your money away. Analyzing the key information contained in Medicover's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Medicover Key Financial Ratios

There are many critical financial ratios that Medicover's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medicover AB reports annually and quarterly.

Medicover Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medicover's current stock value. Our valuation model uses many indicators to compare Medicover value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicover competition to find correlations between indicators driving Medicover's intrinsic value. More Info.
Medicover AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  0.92  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicover AB is roughly  1.09 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicover's earnings, one of the primary drivers of an investment's value.

Medicover AB Systematic Risk

Medicover's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medicover volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Medicover AB correlated with the market. If Beta is less than 0 Medicover generally moves in the opposite direction as compared to the market. If Medicover Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medicover AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medicover is generally in the same direction as the market. If Beta > 1 Medicover moves generally in the same direction as, but more than the movement of the benchmark.

Medicover December 2, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Medicover help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medicover AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medicover AB based on widely used predictive technical indicators. In general, we focus on analyzing Medicover Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medicover's daily price indicators and compare them against related drivers.

Complementary Tools for Medicover Stock analysis

When running Medicover's price analysis, check to measure Medicover's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicover is operating at the current time. Most of Medicover's value examination focuses on studying past and present price action to predict the probability of Medicover's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicover's price. Additionally, you may evaluate how the addition of Medicover to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets